Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

[Pharmacological profiles and clinical effects of blonanserin (Lonasen) on schizophrenia].

Ishibashi T, Nishikawa H, Une T, Nakamura H.

Nihon Yakurigaku Zasshi. 2008 Dec;132(6):351-60. Review. Japanese. No abstract available.

PMID:
19075531
2.

Assessment of molecular cytogenetic methods for the detection of chromosomal abnormalities.

Une T, Yokoyama Y, Ninomiya S, Shinozuka M, Maruyama H, Morishima T.

Acta Med Okayama. 2006 Oct;60(5):279-87.

3.

Unique maternal deletion of 15q in a patient with some symptoms of Prader-Willi syndrome.

Ninomiya S, Yokoyama Y, Kawakami M, Une T, Maruyama H, Morishima T.

Pediatr Int. 2005 Oct;47(5):541-5.

PMID:
16190961
4.

Syntheses and properties of the major hydroxy metabolites in humans of blonanserin AD-5423, a novel antipsychotic agent.

Ochi T, Sakamoto M, Minamida A, Suzuki K, Ueda T, Une T, Toda H, Matsumoto K, Terauchi Y.

Bioorg Med Chem Lett. 2005 Feb 15;15(4):1055-9.

PMID:
15686911
5.

Effect of AD-5423 on animal models of schizophrenia: phencyclidine-induced behavioral changes in mice.

Nagai T, Noda Y, Une T, Furukawa K, Furukawa H, Kan QM, Nabeshima T.

Neuroreport. 2003 Feb 10;14(2):269-72.

PMID:
12598744
6.
7.

[Animal models of psychiatric disorder and their validity--from the perspective of behavioral pharmacology].

Yamamoto T, Une T.

Nihon Yakurigaku Zasshi. 2002 Sep;120(3):173-80. Review. Japanese.

PMID:
12271512
8.

Maternal origin of a unique extra chromosome, der(9)(pter-->q13::q13-->q12:) in a girl with typical trisomy 9p syndrome.

Teraoka M, Narahara K, Yokoyama Y, Ninomiya S, Mizuta S, Une T, Seino Y.

Am J Med Genet. 2001 Jul 22;102(1):25-8.

PMID:
11471168
9.

Isoforms of caveolin-1 and caveolar structure.

Fujimoto T, Kogo H, Nomura R, Une T.

J Cell Sci. 2000 Oct;113 Pt 19:3509-17.

10.

Pharmacologic properties of a novel Ca2+ entry blocker, AJ-2615, in vitro.

Okamura H, Fujitani B, Furukawa K, Une T, Nukuda T, Komiya M, Kurokawa M.

J Cardiovasc Pharmacol. 1993 Dec;22(6):804-9.

PMID:
7509897
11.

Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties.

Oka M, Noda Y, Ochi Y, Furukawa K, Une T, Kurumiya S, Hino K, Karasawa T.

J Pharmacol Exp Ther. 1993 Jan;264(1):158-65.

PMID:
8093723
13.

Significance of the methyl group on the oxazine ring of ofloxacin derivatives in the inhibition of bacterial and mammalian type II topoisomerases.

Hoshino K, Sato K, Akahane K, Yoshida A, Hayakawa I, Sato M, Une T, Osada Y.

Antimicrob Agents Chemother. 1991 Feb;35(2):309-12.

14.

Preparation of monoclonal antibody to V antigen from Yersinia pestis.

Sato K, Nakajima R, Hara F, Une T, Osada Y.

Contrib Microbiol Immunol. 1991;12:225-9. No abstract available.

PMID:
1935094
15.

Interaction of Yersinia pestis with mouse peritoneal macrophages in vitro.

Nakajima R, Namba K, Ishida Y, Une T, Osada Y.

Contrib Microbiol Immunol. 1991;12:219-24. No abstract available.

PMID:
1657519
16.

Inhibitory effects of quinolones on murine hematopoietic progenitor cells and eukaryotic topoisomerase II.

Akahane K, Hoshino K, Sato K, Kimura Y, Une T, Osada Y.

Chemotherapy. 1991;37(3):224-6.

PMID:
1653684
17.

In-vitro and in-vivo activity of DR-3355, an optically active isomer of ofloxacin.

Tanaka M, Otsuki M, Une T, Nishino T.

J Antimicrob Chemother. 1990 Nov;26(5):659-66.

PMID:
2079448
18.

Stimulation of macrophages by muroctasin to produce colony-stimulating factors.

Akahane K, Yamaguchi F, Kita Y, Une T, Osada Y.

Arzneimittelforschung. 1990 Feb;40(2 Pt 1):179-83.

PMID:
1692219
19.

Purification and some properties of a hemolysin from the poisonous mushroom Rhodophyllus rhodopolius.

Suzuki K, Une T, Yamazaki M, Takeda T.

Toxicon. 1990;28(9):1019-28.

PMID:
2260101
20.

Protective role of complement in the development of experimental pneumococcal pneumonia in mice.

Nakajima R, Namba K, Ishida Y, Une T, Osada Y.

Chemotherapy. 1990;36(4):287-93.

PMID:
2147644
21.

Influences of cephem antibiotics on the immune response in mice.

Akahane K, Furuhama K, Kato M, Une T, Onodera T.

Chemotherapy. 1990;36(4):300-7.

PMID:
2123769
22.

Determination of ofloxacin in bronchoalveolar lavage fluid by high-performance liquid chromatography and fluorimetric detection.

Matsubayashi K, Une T, Osada Y.

J Chromatogr. 1989 Oct 27;495:354-7. No abstract available.

PMID:
2613823
23.
24.

Inhibitory effects of quinolones on DNA gyrase of Escherichia coli and topoisomerase II of fetal calf thymus.

Hoshino K, Sato K, Une T, Osada Y.

Antimicrob Agents Chemother. 1989 Oct;33(10):1816-8.

25.
26.

Sub-inhibitory and post-antibiotic effects of an optically active isomer of ofloxacin.

Tanaka M, Une T, Osada Y.

Arzneimittelforschung. 1989 Jul;39(7):750-4.

PMID:
2506868
27.

Chemotherapeutic efficacy of ofloxacin against experimental pneumonia with Pseudomonas aeruginosa in guinea pigs.

Otani T, Nakajima R, Hashimoto S, Iigo Y, Ishida Y, Une T, Osada Y.

Arzneimittelforschung. 1989 Jun;39(6):694-7.

PMID:
2775337
28.

Pseudo-Hamiltonian approach to a theory of effective interactions in the particle-hole channel: Microscopic foundations.

Klein A, Une T.

Phys Rev C Nucl Phys. 1988 Oct;38(4):1897-1910. No abstract available.

PMID:
9955001
29.

Pseudo-Hamiltonian approach to a theory of effective interactions in the particle-hole channel: Phenomenology.

Klein A, Une T.

Phys Rev C Nucl Phys. 1988 Oct;38(4):1886-1896. No abstract available.

PMID:
9955000
30.

In vitro activity of DR-3355, an optically active ofloxacin.

Une T, Fujimoto T, Sato K, Osada Y.

Antimicrob Agents Chemother. 1988 Sep;32(9):1336-40.

31.

Penetrability of ofloxacin into cultured epithelial cells and macrophages.

Une T, Osada Y.

Arzneimittelforschung. 1988 Sep;38(9):1265-7.

PMID:
3066365
32.

Beneficial effect of muroctasin on experimental leukopenia induced by cyclophosphamide or irradiation in mice.

Nakajima R, Ishida Y, Yamaguchi F, Otani T, Ono Y, Nomura M, Une T, Osada Y.

Arzneimittelforschung. 1988 Jul;38(7A):986-92.

PMID:
3263871
33.

Phase I study and clinical pharmacological study of muroctasin.

Ichihara N, Kanazawa R, Sasaki S, Ono K, Otani T, Yamaguchi F, Une T.

Arzneimittelforschung. 1988 Jul;38(7A):1043-69.

PMID:
3263868
34.

Stimulation of non-specific resistance to infection by muroctasin.

Otani T, Une T, Osada Y.

Arzneimittelforschung. 1988 Jul;38(7A):969-76. Review.

PMID:
3056426
35.

Muroctasin, a muramyl dipeptide derivative. An introductory overview.

Tsubura E, Azuma I, Une T.

Arzneimittelforschung. 1988 Jul;38(7A):951-2. Review. No abstract available.

PMID:
3056425
37.

[Studies on the toxic components of Rhodophyllus rhodopolius. I. The biological activities and screening of the toxic principles].

Suzuki K, Une T, Fujimoto H, Yamazaki M.

Yakugaku Zasshi. 1987 Dec;107(12):971-7. Japanese. No abstract available.

PMID:
3450839
38.

Stimulation of non-specific host resistance against Sendai virus and Escherichia coli infections by chitin derivatives in mice.

Iida J, Une T, Ishihara C, Nishimura K, Tokura S, Mizukoshi N, Azuma I.

Vaccine. 1987 Dec;5(4):270-4.

PMID:
2829455
39.

Lack of effectiveness of ofloxacin against experimental syphilis in rabbits.

Une T, Nakajima R, Otani T, Katami K, Osada Y, Otani M.

Arzneimittelforschung. 1987 Sep;37(9):1048-51.

PMID:
3325066
40.

Roles of V antigen in promoting virulence in Yersiniae.

Une T, Nakajima R, Brubaker RR.

Contrib Microbiol Immunol. 1987;9:179-85. No abstract available.

PMID:
3665496
41.

In vitro activity of DQ-2556, a new cephalosporin.

Fujimoto T, Otani T, Nakajima R, Une T, Osada Y.

Antimicrob Agents Chemother. 1986 Oct;30(4):611-3.

42.

Antichlamydial activity of ofloxacin.

Hirai K, Une T.

Microbiol Immunol. 1986;30(5):445-50.

43.

Chemotherapeutic efficacy of ofloxacin on renal and subcutaneous infection models with Staphylococcus aureus in mice.

Fujimoto T, Sato M, Katami K, Osada Y, Tsumura M, Tachizawa H, Une T.

Chemotherapy. 1986;32(3):291-8.

PMID:
3458566
44.

In vitro and in vivo activities of DN-9550, a new broad-spectrum cephalosporin.

Une T, Otani T, Sato M, Ikeuchi T, Osada Y, Ogawa H, Sato K, Mitsuhashi S.

Antimicrob Agents Chemother. 1985 Apr;27(4):473-8.

45.

Roles of V antigen in promoting virulence and immunity in yersiniae.

Une T, Brubaker RR.

J Immunol. 1984 Oct;133(4):2226-30.

PMID:
6381597
46.
47.

Restoration by MDP-Lys (L18) of resistance to Pseudomonas pneumonia in immunosuppressed guinea pigs.

Otani T, Katami K, Une T, Osada Y, Ogawa H.

Microbiol Immunol. 1984;28(9):1077-82. No abstract available.

49.

Polymorphonuclear leukocyte activation by a synthetic muramyl dipeptide analog.

Osada Y, Otani T, Sato M, Une T, Matsumoto K, Ogawa H.

Infect Immun. 1982 Dec;38(3):848-54.

50.

Supplemental Content

Support Center